Previous 10 | Next 10 |
Mustang Bio ( MBIO -11.6% ) is down on almost 50% higher volume in reaction to its public offering of 6.875M common shares at $4 per share. More news on: Mustang Bio, Inc., Healthcare stocks news, Stocks on the move, Read more ...
NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumo...
MICT (NASDAQ: MICT ) -29% . More news on: MICT, Inc., Micro Focus International plc, Precipio, Inc., Stocks on the move, , Read more ...
NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumo...
- Biotech and healthcare stocks are loved by traders for their big price moves, which can happen when a company makes progress (or faces problems) with their developmental products like drugs and devices. Results from Phase I, II and III clinical studies, and FDA or European approvals (and r...
Mustang Bio ( MBIO ) surged higher the prior week, after it highlighted substantially positive data in a phase 1/2 study using its gene therapy to treat patients with X-linked severe combined immunodeficiency ((XSCID)). It was shown that treatment with MB-107 was able to restore the immu...
Mustang Bio, Inc. ( MBIO ) soared last Thursday after the very successful results of its gene therapy, MB-107, for X-linked Severe Combined Immunodeficiency, or X-SCID, were published in the New England Journal of Medicine. The therapy, licensed from the St. Jude Children's Research Hospital, ...
Biotech Brief: Optimistic Outlook Growing for Multi-Billion Dollar Medical Device Industry April 23, 2019 Palm Beach, FL –April 23, 2019 – A recent industry article reported on an optimistic overview concerning the Medical Device Industry. It said: “The medical...
Yangtze River Port and Logistics (NASDAQ: YRIV ) -13% . More news on: Yangtze River Port and Logistics Limited, Mustang Bio, Inc., CannTrust Holdings Inc., Stocks on the move, , Read more ...
What an incredible two days it has been for Mustang Bio (NASDAQ:MBIO). On Wednesday, April 17, the company announced that it entered a licensing agreement with St. Jude Children’s Research Hospital to develop the lentiviral gene therapy to treat “bubble boy” disease. ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB). The update note includes information on the Enveric Bioscience’s ma...
WORCESTER, Mass., June 21, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficul...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...